Journal of Medicinal Chemistry p. 4401 - 4410 (2019)
Update date:2022-08-05
Topics:
Riggs, Jennifer R.
Elsner, Jan
Cashion, Dan
Robinson, Dale
Tehrani, Lida
Nagy, Mark
Fultz, Kimberly E.
Krishna Narla, Rama
Peng, Xiaohui
Tran, Tam
Kulkarni, Ashutosh
Bahmanyar, Sogole
Condroski, Kevin
Pagarigan, Barbra
Fenalti, Gustavo
Lebrun, Laurie
Leftheris, Katerina
Zhu, Dan
Boylan, John F.
Triple negative breast cancer (TNBC) is an aggressive disease with high relapse rates and few treatment options. Outlined in previous publications, we identified a series of potent, dual TTK/CLK2 inhibitors with strong efficacy in TNBC xenograft models. P
View MoreShandong united-rising pharmaceutical cooperation.,ltd.
Contact:008653187965009
Address:171No., Jing5 Road, Shizhong District, Jinan, China
SHANDONG YUANLIAN CHEMICAL CO.,LTD.
website:http://www.yuanlianchem.com
Contact:+86-537-3739818
Address:XINMIN STREET, JIAXIANG COUNTY
HENAN NEW BLUE CHEMICAL CO.,LTD
website:http://www.newbluechem.com
Contact:86-371-55170693/55170694
Address:Zhengzhou International Trade New Territory,Jinshui District,Zhengzhou ,China
Hangzhou jls Flame Retardants Chemical Co.,Ltd
Contact:+86-571-87250387/87250386
Address:MOGANSHAN RODA 1418# SHANGCHENG INDUSTRIAL PARK
ShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD,Minhang District
Doi:10.1021/ol503655a
(2015)Doi:10.3987/com-02-9607
(2003)Doi:10.1016/S0022-328X(00)83682-7
(1974)Doi:10.1248/cpb.22.2004
(1974)Doi:10.1021/jo00896a027
(1975)Doi:10.1021/ja01559a069
(1957)